Search Results - "Waddleton D"

Author index.

Source: European Journal of Biochemistry. 12/15/95, Vol. 234 Issue 3, p976-991. 16p.

Identification of novel PTP1B inhibitor for the treatment of LPS-induced myocardial apoptosis: machine learning based virtual screening and biological evaluation.

Authors: Dong, Xu Shang, Bing Li, Xin et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2025, Vol. 40 Issue 1, p1-15. 15p.

An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid Derivatives.

Authors: Maccari, Rosanna Ottanà, Rosaria Talagayev, Valerij et al.

Source: Pharmaceuticals (14248247). Dec2025, Vol. 18 Issue 12, p1863. 37p.

Targeting Protein Tyrosine Phosphatases via PROteolysis-TArgeting Chimeras (PROTACs): Current Developments and Prospects.

Authors: Maccari, Rosanna¹ (AUTHOR)

Source: Molecules. Nov2025, Vol. 30 Issue 22, p4449. 27p.

TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents.

Authors: Gaona-López, Carlos Méndez-Álvarez, Domingo Moreno-Rodríguez, Adriana et al.

Source: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p6238. 20p.

Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience.

Authors: Guerra, Prisca Di Cesare, Antonella Rosi, Elia et al.

Source: Life (2075-1729). Mar2024, Vol. 14 Issue 3, p395. 12p.

Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach.

Authors: Biswas, Partha Bibi, Shabana Yousafi, Qudsia et al.

Source: Molecules. Apr2023, Vol. 28 Issue 7, p2977. 31p.

An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1.

Authors: Rahman, MD. Hasanur Biswas, Partha Dey, Dipta et al.

Source: Life (2075-1729). Nov2022, Vol. 12 Issue 11, p1764. 19p.

Identifying Human PTP1B Enzyme Inhibitors from Marine Natural Products: Perspectives for Developing of Novel Insulin-Mimetic Drugs.

Authors: Casertano, Marcello Genovese, Massimo Piazza, Lucia et al.

Source: Pharmaceuticals (14248247). Mar2022, Vol. 15 Issue 3, p325. 22p.

Molecular mechanisms mediate roflumilast protective effect against isoprenaline-induced myocardial injury.

Authors: Refaie, Marwa Monier Mahmoud Ibrahim, Manar Fouli Gaber Fawzy, Michael Atef et al.

Source: Immunopharmacology & Immunotoxicology. Dec2023, Vol. 45 Issue 6, p650-662. 13p.

Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine.

Authors: Maccari, Rosanna Ottanà, Rosaria

Source: International Journal of Molecular Sciences. Jun2023, Vol. 24 Issue 11, p9621. 25p.

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches.

Authors: Lugnier, Claire¹ (AUTHOR) claire.lugnier@unistra.fr

Source: International Journal of Molecular Sciences. Sep2022, Vol. 23 Issue 18, pN.PAG-N.PAG. 22p.

Effects of inhibition of phosphodiesterase 3B in pancreatic islets on insulin secretion: a potential link with some stimulatory pathways.

Authors: Kilanowska, Agnieszka Szkudelski, Tomasz

Source: Archives of Physiology & Biochemistry. Jun2021, Vol. 127 Issue 3, p250-257. 8p.

APELIN INHIBITS INSULIN SECRETION IN PANCREATIC β-CELLS BY ACTIVATION OF PI3-KINASE-PHOSPHODIESTERASE 3B.

Authors: Guo, Lin Li, Qiang Wang, Wei et al.

Source: Endocrine Research. 2009, Vol. 34 Issue 4, p142-154. 13p. 5 Graphs.

Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells.

Authors: Pratt, Evan P. S. Harvey, Kyle E. Salyer, Amy E. et al.

Source: PLoS ONE. 8/23/2019, Vol. 14 Issue 8, p1-27. 27p.

Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.

Authors: Chen, Xi Liu, Xia Gan, Qiang et al.

Source: BioMed Research International. 1/8/2019, p1-11. 11p.

Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK-648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction.

Authors: Plock, N Vollert, S Mayer, M et al.

Source: CTS: Clinical & Translational Science. May2017, Vol. 10 Issue 3, p185-193. 9p.

RNA-Seq Analysis of Abdominal Fat in Genetically Fat and Lean Chickens Highlights a Divergence in Expression of Genes Controlling Adiposity, Hemostasis, and Lipid Metabolism.

Authors: Resnyk, Christopher W. Chen, Chuming Huang, Hongzhan et al.

Source: PLoS ONE. 10/7/2015, Vol. 10 Issue 10, p1-41. 41p.

DOCKING STUDIES OF TYPICAL CONFORMATIONS OF PROTEIN TYROSINE PHOSPHATASE 1B.

Authors: Tanin, Volodymyr Tanchuk, Vsevolod

Source: Proceedings of National Aviation University. 2014, Vol. 60 Issue 3, p87-92. 6p.

A review of recent progress (2002-2012) on the biological activities of pyrazoles.

Authors: Pérez-Fernández, Ruth Goya, Pilar Elguero, José

Source: ARKIVOC: Online Journal of Organic Chemistry. 2014, p233-293. 62p.